Labiotech.eu

News and Trends 23 May 2016

To Be – or Not To Be, a Virtual Biotech?

Many new biotechs start off as virtual companies. But at each stage of development, you always end up asking whether you should stay virtual or build your own in-house wet labs. What are the pros and cons of being virtual? And is there a more pragmatic “semi-virtual” approach? Pros and Cons of being Virtual Biotechs […]

May 23, 2016 - 5 minutesmins - By Dani Bancroft

News and Trends 23 May 2016

Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased…

Yes, everyone is talking about how Germany’s Pharma giant Bayer has made a $62 billion offer for the infamous chemicals conglomerate Monsanto. And not many like it. Bayer’s products mostly consist of human and veterinary pharmaceuticals, consumer healthcare products, agricultural chemicals, biotechnological products, and high value polymers. Monsanto on the other hand is notorious for its agricultural chemicals, GMOs […]

May 23, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 23 May 2016

Irish NASH drug will also be investigated for Major Lung Diseases

DS Biopharma was already studying one of its bioactive lipids for non-alcoholic steatohepatitis (NASH). The candidate will now also target chronic obstructive pulmonary disease (COPD). Headquartered in Dublin (Ireland), DS Biopharma is working on new medicines for medical unmet needs, such as fibrosis. This development of fibrous tissue can affect the lungs, liver or heart. DS has […]

May 23, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 23 May 2016

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

Researchers from University of Cambridge and the Wellcome Trust Sanger Institute have discovered that Ebola can still be transmitted through sex and breastfeeding after quarantine – causing ‘flare-ups’ even though the epidemic has ended. Without effective vaccines or treatments for Ebola infection, the 2014’s outbreak in West Africa was contained due to public health measures. These […]

May 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 20 May 2016

This Israel-based Biotech startup is currently raising €17M to enable Precision Medicine

InnVentis is aiming big in the field of precision medicine. With novel molecular diagnostics and big data, it wants to tackle complicated conditions like Rheumatoid Arthiritis. Just starting out, InnVentis is an Israeli Biotech founded by Thomas Wilckens, a German expert in precision medicine originally from Munich. He and his team decided to move to Israel for financial reasons […]

May 20, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 20 May 2016

Biotech of the Week: Immunicum, Immuno-oncology made in Sweden

We like Scandinavia so much we just don’t want to leave, therefore, we’re heading back East again! This time, Gothenburg is our destination. Being the second biggest city in Sweden and having the biggest harbor in the Northern countries (and once the hosting city for the Eurovision Song Contest in 1985) it is also where […]

May 20, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 19 May 2016

DIY Biology catches on with the UK’s first BioHackacthon

The hackathon phenomena is knocking on biology’s door. The first UK Biohackathon will be held at the University of Cambridge in June, to learn and create with SynBio. Hackathons are massively popular events in computer programming, joining people during a short period to create a hands-on project. The concept has now spread to biology – more […]

May 19, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 19 May 2016

FDA approves First ever antibody to target Cancer PD-L1

Roche has received market approval for atezolizumab to treat a common type of bladder cancer. It’s the 3rd checkpoint inhibitor on the market, and the first to target PD-L1. Immuno-oncology is a hype field that promises to revolutionize cancer treatment, with a lot of active research and big deals (like the €600M deal between argenx […]

May 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 19 May 2016

Bone Therapeutics switches to allogeneic for Universal Bone Cell Therapy

Bone Therapeutics is moving forward with a new phase II trial targeting severe osteroporosis – but this time with its allogeneic bone cell therapy (ALLOB). This type of therapy is easier to administrate, and could reach more patients in need. Bone Therapeutics is based in Gosselies (Belgium) and is developing cell therapies to treat conditions […]

May 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 18 May 2016

Bayer claims CRISPR Patents for Gene-Editing Agreements

Bayer has signed a patent license agreement with ERS Genomics, that controls patents for the CRISPR-Cas9 system – a breakthrough gene-editing technology. Bayer Lifescience Center (BLSC) is the innovation division of German Giant Bayer, which aims to address challenges in the pharmaceutical and agro-industry. Its strategy is to establish collaborations with innovative Biotechs, and create a […]

May 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 18 May 2016

Polish Bioinformatics company backs US movement into Microbiome Research

In Kraków, the Bioinformatics company Ardigen has now partnered up with a US based Microbiome startup, EpiBiome, which is looking for the answer to antibiotic resistance. This is another example of cross-Atlantic collaboration in the Microbiome world, just as President Obama pledges €105M ($121M) to the up and coming field of therapeutics. It’s a growing area of research, and as […]

May 18, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 18 May 2016

New UK Biotech could treat Diabetes with Lab-grown Cells

Islexa is the new baby of Catapult and the University of Aberdeen, which will be developing laboratory grown islets. This could replace insulin production in patients with type 1 diabetes. One of the coolest Biotechs in London, Catapult has joined the University of Aberdeen to create a new Biotech that could revolutionize treatment of type […]

May 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

To Be – or Not To Be, a Virtual Biotech?

Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased…

Irish NASH drug will also be investigated for Major Lung Diseases

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

This Israel-based Biotech startup is currently raising €17M to enable Precision Medicine

Biotech of the Week: Immunicum, Immuno-oncology made in Sweden

DIY Biology catches on with the UK’s first BioHackacthon

FDA approves First ever antibody to target Cancer PD-L1

Bone Therapeutics switches to allogeneic for Universal Bone Cell Therapy

Bayer claims CRISPR Patents for Gene-Editing Agreements

Polish Bioinformatics company backs US movement into Microbiome Research

New UK Biotech could treat Diabetes with Lab-grown Cells

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!